Abstracts of papers

It has now become common sense to say that treatment paradigms in oncology are changing. From large range, toxic, deleterious treatments that had only a very small margin of benefit we are now going to targeted, more specific, more effective therapies. This change challenges research mechanisms, tre...

Full description

Bibliographic Details
Main Author: M Lemort
Format: Article
Language:English
Published: Ubiquity Press 2010-06-01
Series:Journal of the Belgian Society of Radiology
Online Access:https://www.jbsr.be/articles/361
Description
Summary:It has now become common sense to say that treatment paradigms in oncology are changing. From large range, toxic, deleterious treatments that had only a very small margin of benefit we are now going to targeted, more specific, more effective therapies. This change challenges research mechanisms, treatment habits and health economics. Even if cancer is a widespread disease and a major cause of chronic illness and mortality, costs of large-scale research and development of a competitive business model begin hampering innovation.
ISSN:2514-8281